Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

71.91
Delayed Data
As of 4:15pm ET
 -1.16 / -1.59%
Today’s Change
70.83
Today|||52-Week Range
103.10
+0.42%
Year-to-Date
Biotech Sector to See M&A, Earnings Action
11:13am / TheStreet.com - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content
3 Bargain Stocks to Buy Now
9:11am / MotleyFool.com - Paid Partner Content
Stock Market News for January 12, 2017
Jan 12 / Zacks.com - Paid Partner Content
Donald Trump Just Leveled Drug Companies With These 4 Words
Jan 14 / MotleyFool.com - Paid Partner Content
Is the Options Market Predicting a Spike in Gilead Sciences (GILD) Stock?
Jan 12 / Zacks.com - Paid Partner Content
Rhenman & Partners Asset Management AB Buys Gilead Sciences Inc, Medtronic PLC, Pfize...
Jan 13 / GuruFocus News - Paid Partner Content
Gilead (GILD) HBV Drug Vemlidy Receives European Approval
Jan 12 / Zacks.com - Paid Partner Content
Jerome Dodson Buys Allergan PLC, McKesson Corp, Progressive Corp, Sells Ciena Corp, C...
Jan 12 / GuruFocus News - Paid Partner Content
Stock Market Roundup Jan. 11: Health Sector Lower on Trump "Murder" Comment
Jan 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close73.07
Today’s open72.92
Day’s range71.73 - 72.92
Volume11,689,454
Average volume (3 months)9,624,493
Market cap$96.3B
Dividend yield2.61%
Data as of 4:15pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-9.32%
Earnings growth (next 5 years)-0.55%
Revenue growth (last year)+28.71%
P/E ratio6.7
Price/Sales4.80
Price/Book5.61

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.32-0.85%
BIIBBiogen-1.74-0.61%
ILMNIllumina Inc-2.10-1.29%
ARIAARIAD Pharmaceutical...-0.05-0.21%
Data as of 4:15pm ET, 01/17/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$2.61
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts


Search for Jobs